| Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis N Buscemi, B Vandermeer, N Hooton, R Pandya, L Tjosvold, L Hartling, ... Bmj 332 (7538), 385-393, 2006 | 594 | 2006 |
| Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C] raclopride study in healthy men M Leyton, I Boileau, C Benkelfat, M Diksic, G Baker, A Dagher Neuropsychopharmacology 27 (6), 1027-1035, 2002 | 518 | 2002 |
| The efficacy and safety of exogenous melatonin for primary sleep disorders a meta-analysis N Buscemi, B Vandermeer, N Hooton, R Pandya, L Tjosvold, L Hartling, ... Journal of general internal medicine 20 (12), 1151-1158, 2005 | 492 | 2005 |
| Modeling sensitization to stimulants in humans: an [11C] raclopride/positron emission tomography study in healthy men I Boileau, A Dagher, M Leyton, RN Gunn, GB Baker, M Diksic, C Benkelfat Archives of general psychiatry 63 (12), 1386-1395, 2006 | 437 | 2006 |
| Glutamate system, amyloid β peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology TJ Revett, GB Baker, J Jhamandas, S Kar Journal of Psychiatry and Neuroscience 38 (1), 6-23, 2013 | 399 | 2013 |
| Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4 J Fang, M Bourin, GB Baker Naunyn-Schmiedeberg's archives of pharmacology 359, 147-151, 1999 | 312 | 1999 |
| A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates A Holt, DF Sharman, GB Baker, MM Palcic Analytical biochemistry 244 (2), 384-392, 1997 | 310 | 1997 |
| Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions L Urichuk, TI Prior, S Dursun, G Baker Current drug metabolism 9 (5), 410-418, 2008 | 294 | 2008 |
| Bioactive contaminants leach from disposable laboratory plasticware GR McDonald, AL Hudson, SMJ Dunn, H You, GB Baker, RM Whittal, ... Science 322 (5903), 917-917, 2008 | 287 | 2008 |
| 3, 4-Methylenedioxy analogues of amphetamine: defining the risks to humans KM Hegadoren, GB Baker, M Bourin Neuroscience & Biobehavioral Reviews 23 (4), 539-553, 1999 | 264 | 1999 |
| Evidence that serotonin mediates non-cholinergic neocortical low voltage fast activity, non-cholinergic hippocampal rhythmical slow activity and contributes to intelligent behavior CH Vanderwolf, GB Baker Brain research 374 (2), 342-356, 1986 | 259 | 1986 |
| Interactions between the cytochrome P450 system and the second-generation antipsychotics TI Prior, GB Baker Journal of Psychiatry and Neuroscience 28 (2), 99-112, 2003 | 244 | 2003 |
| Extracellular glutamate and other amino acids in experimental intracerebral hemorrhage: an in vivo microdialysis study AI Qureshi, Z Ali, MFK Suri, A Shuaib, G Baker, K Todd, LR Guterman, ... Critical care medicine 31 (5), 1482-1489, 2003 | 235 | 2003 |
| Impaired neurosteroid synthesis in multiple sclerosis F Noorbakhsh, KK Ellestad, F Maingat, KG Warren, MH Han, L Steinman, ... Brain 134 (9), 2703-2721, 2011 | 228 | 2011 |
| Melatonin for treatment of sleep disorders: summary N Buscemi, B Vandermeer, R Pandya, N Hooton, L Tjosvold, L Hartling, ... AHRQ evidence report summaries, 2004 | 227 | 2004 |
| Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity JP Redrobe, M Bourin, MC Colombel, GB Baker Psychopharmacology 138 (1), 1-8, 1998 | 217 | 1998 |
| An overview of animal models related to schizophrenia IR Winship, SM Dursun, GB Baker, PA Balista, L Kandratavicius, ... The Canadian Journal of Psychiatry 64 (1), 5-17, 2019 | 205 | 2019 |
| Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model V Labrie, R Fukumura, A Rastogi, LJ Fick, W Wang, PC Boutros, ... Human molecular genetics 18 (17), 3227-3243, 2009 | 204 | 2009 |
| A critical review of neurobiological factors involved in the interactions between chronic pain, depression, and sleep disruption PA Boakye, C Olechowski, S Rashiq, MJ Verrier, B Kerr, M Witmans, ... The Clinical Journal of Pain 32 (4), 327-336, 2016 | 187 | 2016 |
| Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects SH Kennedy, SM McCann, M Masellis, RS McIntyre, J Raskin, G McKay, ... Journal of Clinical Psychiatry 63 (3), 181-186, 2002 | 184 | 2002 |
